Bile duct tumours

Current Diagnostic Pathology

Volumn 8, Issue 3, 2002, Pages 160-171

  Standish, R A ^a   Davies, S E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Benign biliary tumours; Extrahepatic cholangiocarcinoma; Intrahepatic cholangiocarcinoma

Indexed keywords

CA 19-9 ANTIGEN; CARCINOGEN;

ADENOMA; BILE DUCT CARCINOMA; BILE DUCT CYST; BILE DUCT TUMOR; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CLONORCHIS SINENSIS; CONFERENCE PAPER; CYSTADENOMA; CYTOLOGY; DISEASE ASSOCIATION; DYSPLASIA; ENVIRONMENTAL EXPOSURE; FAR EAST; HUMAN; OPISTHORCHIS VIVERRINI; PAPILLOMATOSIS; PARASITIC LIVER DISEASE; PATHOGENESIS; PRECANCER; PRIMARY SCLEROSING CHOLANGITIS; UNITED KINGDOM;

EID: 0036619814     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2002.0113     Document Type: Conference Paper

References (48)

1. Alison M. Small fry starting to make waves. Comment on: Gut 2001; 48: 816-820 and Gut 2001; 48: 754-755.
2. Alison M. Small fry starting to make waves. Comment on: Gut 2001; 48: 816-820 and Gut 2001; 48: 754-755.
3. Anthony P P. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In: MacSween R N M, Burt A D, Portmann B C, Ishak K G, Scheuer P J, Anthony P P (eds). Pathology of the Liver, 4th edn. Edinburgh: Churchill Livingstone, 2002; 711-775.
4. de Groen P C, Gores G J, LaRusso N F, Gunderson L L, Nagorney D M. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378.
5. Menzel J, Domschke W. Intraductal ultrasound in the biliary tract. Curr Gastroenterol Rep 2001; 3: 141-146.
6. Beckingham I J, Krige J E J. Liver tumours. BMJ 2001; 322: 477-480.
7. Vick D J, Goodman Z D, Deavers M T et al. Ciliated hepatic foregut cyst: a study of 6 cases and review of the literature. Am J Surg Pathol 1999; 23: 671-677.
8. Allaire G S, Rabin L, Ishak K G, Sesterhenn I A. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol 1988; 12: 708-715.
9. Bhathal P S, Hughes N R, Goodman Z D. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol 1996; 20: 858-864.
10. Albores-Saavedra J, Hoang M P, Murakata L A et al. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. Am J Surg Pathol 2001; 25: 956-960.
11. Devaney K, Goodman Z D, Ishak K G. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078-1091.
12. Horsmans Y, Laka A, Gigot J F et al. Serum and cystic fluid CA 199 determinations as a diagnostic help in liver cysts of uncertain nature. Liver 1996; 16: 255-257.
13. Thomas J A, Scriven M W, Puntis M C et al. Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer 1992; 709: 1841-1846.
14. Davis W, Chow M, Nagorney D. Extrahepatic biliary cystadenomas and cystadenocarcinoma. Ann Surg 1995; 222: 619-625.
15. Terada T, Kitamura Y, Ohta T, Nakanuma Y. Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas. Virchows Arch 1997; 430: 37-40.
16. Wheeler D A, Edmondson H A. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer 1985; 56: 1434-1445.
17. Scott F R, More L, Dhillon A P. Hepatobiliary cystadenoma with mesenchymal stroma: expression of oestrogen receptors in formalin-fixed tissue. Histopathology 1995; 26: 555-558.
18. Grayson W, Teare J, Myburgh J A, Paterson A C. Immunohistochemical demonstration of progesterone receptor in hepatobiliary cystadenoma with mesenchymal stroma. Histopathology 1996; 29: 461-463.
19. Woods G L. Biliary cystadenocarcinoma. Case report of hepatic malignancy originating in benign cystadenoma. Cancer 1981; 47: 2936-2940.
20. Rambaud S, Nores J M, Meeus F, Paolaggi J A. Malignant papillomatosis of the bile ducts: a new indication for liver transplantation? Am J Gastroenterol 1989; 84: 448-449.
21. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357.
22. Taylor-Robinson S D, Toledano M B, Arora S et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001; 48: 754-755,
23. Jarnagin W R. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 2000; 19: 156-176.
24. Ishak K G, Goodman Z D, Thomas Stocker J. Intrahepatic cholangiocarcinoma and other malignant biliary tumors. In: Rosai J (ed.). Atlas of Tumor Pathology, Vol. 31, 3rd series: Tumors of the Liver and Intrahepatic Bile Ducts. Washington DC: Armed Forces Institute of Pathology, 1999; 245-270.
25. Jain D, Sarode V R, Abdul-Karim F W et al. Evidence for the neoplastic transformation of Von-Meyenburg complexes. Am J Surg Pathol 2000; 24: 1131-1139.
26. Yamamoto M, Takasaki K, Nakano M, Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998; 82: 2145-2149.
27. Albores-Saavedra J, Henson D E, Klimstra D S. Malignant epithelial tumors of the extrahepatic bile ducts. In: Rosai J (ed.). Atlas of Tumor Pathology, Vol 27, 3rd series; Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater. Washington DC: Armed Forces Institute of Pathology, 1998; 181-190.
28. Bannasch P, Schroder C H. Tumours and tumour-like lesions of the liver and biliary tract: pathogenesis of primary liver tumours. In: MacSween R N M, Burt A D, Portmann B C, Ishak K G, Scheuer P J, Anthony P P (eds). Pathology of the Liver, 4th edn. Edinburgh: Churchill Livingstone, 2002; 777-825.
29. Celli A, Que F G, Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Semin Liver Dis 1998; 18: 177-185.
30. Reeves M E, DeMatteo R P. Genes and viruses in hepatobiliary neoplasia. Sem Surg Oncol 2000; 19: 84-93.
31. Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr Gastro Rep 1999; 1: 95-101.
32. Wall W J. Liver transplantation for hepatic and biliary malignancy. Sem Liver Dis 2000; 20: 425-435.
33. Strong R W. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000; 19: 189-199.
34. Prall R T, Lindor K D, Wiesner R H, LaRusso N F. Current therapies and clinical controversies in the management of primary sclerosing cholangitis. Curr Gastro Rep 2000; 2: 99-103.
35. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatitis: an unusual tumour with distinctive clinical and pathological features. Am J Med 1965; 38: 241-256.
36. Sobin L H, Wittekind C (eds). International Union Against Cancer TNM Classification of Malignant Tumours, 5th edn. New York: John Wiley & Sons Inc, 1997.
37. Kajiyama K, Maeda T, Takenaka K et al. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. Am J Surg Pathol 1999; 23: 892-902.
38. Rosai J. Pancreas and ampullary region. In: Rosai J (ed.). Ackerman's Surgical Pathology, 8th edn. St Louis: Mosby, 1996; 969-1013.
39. Isa T, Kusano T, Shimoji H et al. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001; 181: 507-511.
40. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma. J Surg Oncol 1998; 69: 162-167.
41. Weinbrien K, Mutum S S. Pathological aspects of cholangiocarcinoma. J Pathol 1982; 139: 217-238.
42. Chen T C, Ng K F, Kuo T. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component. Mod Pathol 2001; 14: 527-532.
43. Jeng Y M, Chen C L and Hsu H C. Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor. Am J Surg Pathol 2001; 25: 516-520.
44. Rullier A, Le Bail B, Fawaz R. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 2000; 24: 870-876.
45. Shimonishi T, Miyazaki K, Nakanuma Y et al. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 2000; 37: 55-63.
46. Kurzawinski T, Deery A, Dooley J, Dick R, Hobbs K, Davidson B. A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures. Gut 1992; 33: 1675-1677.
47. Kubicka S, Kuhnel F, Flemming P et al. K-ras mutations in the bile of patients with primary sclerosing cholangitis. Gut 2001; 48: 403-408.
48. Stewart C J, Burke G M. Value of p53 immunostaining in pancreatico-biliary brush cytology specimens. Diagn Cytopathol 2000; 23: 308-313.